|
Market Closed -
Bombay S.E.
03:53:02 29/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,787.25 INR | -3.82% |
|
-2.93% | +12.80% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
ETFs positioned on GlaxoSmithKline Pharmaceuticals Limited
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +11.39% | -.--% | 67 M€ | |
| +20.59% | -.--% | 9,273 M€ | |
| +11.87% | -.--% | 27,154 M€ | |
| -11.34% | -.--% | 2,054 M€ | |
| -.--% | 0.39% | 773 M€ | |
| -22.12% | 0.09% | 108 M€ | |
| +16.24% | 0.08% | 611 M€ | |
| +11.62% | 0.07% | 380 M€ | |
| +11.64% | 0.07% | 337 M€ | |
| -12.46% | 0.07% | 2,692 M€ | |
| -9.26% | 0.07% | 2,189 M€ | |
| -11.90% | 0.05% | 5 M€ | |
| +20.32% | 0.04% | 10 M€ | |
| +15.59% | 0.03% | 223 M€ | |
| -.--% | 0.02% | 7 M€ | |
| +17.30% | 0.02% | 61 M€ | |
| 0.00% | 0.02% | 77 M€ | |
| +16.75% | 0.02% | 199 M€ | |
| +41.74% | 0.02% | 592 M€ | |
| +21.80% | 0.02% | 1,021 M€ | |
| +29.63% | 0.02% | 150 M€ | |
| +20.59% | 0.02% | 268 M€ | |
| -.--% | 0.01% | 11 M€ | |
| +12.12% | 0.01% | 12,827 M€ | |
| +16.20% | 0.01% | 24 M€ | |
| +18.19% | 0.01% | 117 M€ | |
| +22.11% | 0.01% | 216 M€ | |
| +10.57% | 0.01% | 3,667 M€ | |
| +24.10% | 0.01% | 57 M€ | |
| +14.75% | 0.01% | 2,339 M€ | |
| +22.73% | 0.01% | 89 M€ | |
| +17.05% | 0.01% | 535 M€ | |
| +24.32% | 0.01% | 1,808 M€ | |
| +19.83% | 0.01% | 189 M€ | |
| +27.27% | 0.01% | 6,575 M€ | |
| +14.59% | 0.01% | 3,276 M€ | |
| +23.99% | 0.01% | 43,353 M€ | |
| +21.55% | 0.01% | 1,403 M€ |
Employees
3,103
Sector
Pharmaceuticals
- Stock Market
- Stocks
- GLAXO Stock
- ETFs GlaxoSmithKline Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
